JAN 23, 2019 01:54 PM PST

Stroke Drug May Prevent Alzheimer

WRITTEN BY: Nouran Amin

According to a study published in the Journal of Experimental Medicine, scientists at the University of Southern California discovered that a drug used for the treatment of stroke may also prevent Alzheimer's disease. The study shows that the brains of Alzheimer-model mice were protected from Alzheimer-like symptoms by a genetically modified version of a human blood protein (activated protein C) called ‘3K3A-APC’. The drug specifically protected the brain by reducing the buildup of toxic amyloid-beta peptides, preventing memory loss, and reducing inflammation—all common features of Alzheimer disease.

Learn more about Alzheimer disease:

3K3A-APC also reduces inflammation and protects both neurons and the cells that line the walls of blood vessels. Besides treating stroke--the protein was also shown to have positive effects on other models of disease including traumatic brain injury (TBI) and multiple sclerosis, and was clinically proven to be safe well-tolerated and capable of reducing intracerebral bleeding. "Because of its neuroprotective, vasculoprotective, and anti-inflammatory activities in multiple models of neurological disorders, we investigated whether 3K3A-APC can also protect the brain from the toxic effects of amyloid-beta toxin in a mouse model of Alzheimer's disease," says Berislav V. Zlokovic, the Director of the Zilkha Neurogenetic Institute at the Keck School of Medicine, University of Southern California.

3K3A-APC (right) greatly reduced the amount of amyloid-beta (green) that accumulated in brains of model mice that develop Alzheimer like symptoms in comparison with no treatment (left).

Credit: Lazic et al., 2019 via Science Daily

In the paper, 3K3A-APC protected the brain by preventing nerve cells from synthesizing an enzyme called BACE1 that in return produces amyloid-beta. Although several different inhibitors of BACE1 have gone through clinical trials, using 3K3A-APC for the inhibition of BACE1 is an alternative approach especially at early stages of the Alzheimer when amyloid-beta has not yet to accumulated to dangerous levels resulting in permanent damage in the brain. "Our present data support the idea that 3K3A-APC holds potential as an effective anti-amyloid-beta therapy for early stage Alzheimer's disease in humans," Zlokovic says.

Source: Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 20, 2019
Drug Discovery & Development
NOV 20, 2019
Drug Reduces Heart Attacks in Diabetic Patients
Recent results from a clinical trial that evaluated the addition of a drug called ‘ticagrelor’ to aspirin were shown to improve clinical outcom...
NOV 20, 2019
Genetics & Genomics
NOV 20, 2019
Can Lifestyle Changes Switch Off Dementia Genes?
Around 50 million people have dementia worldwide, with 10 million new cases emerging each year (World Health Organization: 2019). Most prominent in people ...
NOV 20, 2019
Drug Discovery & Development
NOV 20, 2019
Researchers Can Now Reverse Skin Cancer
Ten years ago, just 5% of people with advanced melanoma (skin cancer) lived more than five years after being diagnosed. Now however, researchers from the I...
NOV 20, 2019
Genetics & Genomics
NOV 20, 2019
Gene-Editing Breakthrough for Cervical Cancer
Researchers at the The Menzies Health Institute Queensland have found a way to use gene therapy CRISPR-Cas9 to treat cervical cancer. The first treatment o...
NOV 20, 2019
Drug Discovery & Development
NOV 20, 2019
Developing Animal-Free Neurotoxin Testing
The need to assess a group of deadly neurotoxins without turning to animal-testing may soon be a possibility. A new animal-free testing technique was recen...
NOV 20, 2019
Drug Discovery & Development
NOV 20, 2019
Antibiotics from the Sea?
Many of the clinically relevant antibiotics are sourced from natural substances, produced by bacteria. But because of the growing threat of antibiotic resi...
Loading Comments...